A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties

John Busby, Liam Murray, Ken Mills, Shu-Dong Zhang, Fabio Liberante, Chris R. Cardwell

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
Original languageEnglish
Pages (from-to)78-86
JournalPharmacoepidemiology and Drug Safety
Issue number1
Publication statusPublished (in print/issue) - 4 Dec 2017


  • breast cancer
  • connectivity mapping
  • drug discovery
  • pharmacoepidemiology

Cite this